Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
ABB LTD. (ABB) CEO Ulrich Spiesshofer on Q2 2018 Results - Earnings Call Transcript

12h seekingalpha
Ladies and gentlemen, good morning or good afternoon. Welcome to the ABB Q2 2018 Results Conference Call. I'm Mirona, the Chorus Call operator. [Operator Instructions] The conference must not be recorded for publication or broadcast.
ABB MS.PRI MS.PRK MS.PRE ABLZF MS.PRF MS.PRG MS MS.PRA BEAV

1
ABB LTD. 2018 Q2 - Results - Earnings Call Slides

19h seekingalpha
The following slide deck was published by ABB LTD. in conjunction with their 2018 Q2 earnings call.
ABB ABLZF

61
The Renewable Revolution

2018-07-18 seekingalpha
With the migration from dirty to clean energy well underway, it’s time to consider whether we have entered the Renewable Revolution.
ABB BP SPWR TM SIEGY SU TSLA TOT FSLR

1
Will Solid End-Market Growth Boost ABB's Earnings in Q2?

2018-07-17 zacks
ABB Ltd (ABB - Free Report) is scheduled to report second-quarter 2018 results on Jul 19.
ABB ABLZF MTW ETN

14
Payton Planar - A Hidden Gem Under The Electric Vehicle Hood

2018-07-16 seekingalpha
Electric Vehicles (EVs) are expected to hit the road en masse over the next several years. Instead of guessing who will win the car manufacturers' race, it’s wise to look under the hood for niche suppliers.
SXI ABB LEA PAY GM.WS.A GM.WS.B GM.WS.C VSH GM GM.WSB POWI

0
What Goes (Irrationally) Up Must Come Down

2018-07-11 seekingalpha
Kuka experienced a wild ride in their share price last year following the Chinese firm Midea taking a majority stake.
ABB KUKAF KUKAY KUKKF HOLI

110
Fuel Cells, No Longer Too Early

2018-07-03 seekingalpha
Occasionally, I find myself accepting that an “out there” investment idea is worth a leap-of-faith – hydrogen fuel cells.
NTLA RDS.B RDS.A TM MS.PRE CRSP MS.PRF MS.PRG RDSB UTX RDSA MS.PRA HMC ABB EDIT MS.PRI MS.PRK RYDBF MS RYDAF AI BLDP

82
Enphase: The New Solar Model, Pay Your Customers To Buy Your Products

2018-06-26 seekingalpha
As demonstrated in the article, the economics clearly demonstrate Enphase will only recoup 21% or ~$15 million of their purchase price over the life of the five-year contract.
ABB FLEX VSLR RUN SPWR TSLA SEDG ENPH

32
Union leaders to meet General Electric in bid to save Virginia jobs

2018-06-12 reuters
NEW YORK (Reuters) - Union leaders plan to meet with General Electric Co on Wednesday in a bid to avert closure of a Virginia factory that makes controls for GE’s power plants, the company and the union said on Tuesday.
ABB GEC GE ABLZF GNE

32
Union leaders to meet General Electric in bid to save Virginia jobs

2018-06-12 channelnewsasia
Union leaders plan to meet with General Electric Co on Wednesday in a bid to avert closure of a Virginia factory that makes controls for GE's power plants, the company and the union said on Tuesday.
ABB GEC GE ABLZF GNE

32
Union leaders to meet General Electric in bid to save Virginia jobs

2018-06-12 reuters
NEW YORK, June 12 (Reuters) - Union leaders plan to meet with General Electric Co on Wednesday in a bid to avert closure of a Virginia factory that makes controls for GE’s power plants, the company and the union said on Tuesday.
ABB GEC GE ABLZF GNE

24
China's Solar Demand Shock Is Not So Simple

2018-06-12 seekingalpha
But what is China doing here? What has caused this move, and what might cause different policy developments in the years to come?
ABB RUN ABLZF FSLR

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ABB / ABB Ltd. on message board site Silicon Investor.

Lazar-babble...... ABB (Asea Brown Boveri) ADR
Whou0027 s Roger Babb? Did Roger Rabbit blab to Roger Babb?
ABT: Abbott Laboratories ABT - Abbott Labs
Softechieu0027s KAABBOOOOMM Thread The Semi-Coherent Anti-American Babble Thread
Berger Tech Fund, GY SWC ITW Lord Abbett Large Cap GF DIZZY CITY-SPEAK..; psycho-babble translations
CUSIP: 000375204